Postępy Dermatologii i Alergologii

Full text

5/2026 vol. 43
Original paper

Serum IL-17 and TWEAK as joint predictors of renal flare in systemic lupus erythematosus

Xiaochang Fan 1

  1. The Second People’s Hospital of Lianyungang, China

Adv Dermatol Allergol 2026; XLIII (5): 577-583

DOI: https://doi.org/10.5114/ada.2026.166083
Data publikacji online: 2026/10/27
Article file
PDiA Serum IL-17.pdf
  1. Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers 2016; 2: 16039.
  2. Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol 2017; 12: 825-35.
  3. Anders HJ, Saxena R, Zhao MH, et al. Lupus nephritis. Nat Rev Nephrol 2020; 16: 565-81.
  4. Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis 2020; 76: 265-81.
  5. Ugarte-Gil MF, Acevedo-Vásquez E, Alarcón GS, et al. The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort. Ann Rheum Dis 2015; 74: 1019-23.
  6. Hanly JG, Urowitz MB, Sanchez-Guerrero J, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007; 56: 265-73.
  7. Birmingham DJ, Irshaid F, Nagaraja HN, et al. The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 2010; 19: 1272-80.
  8. Mok CC, Ho LY, Ying SK, et al. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med 2016; 129: 729-36.
  9. Davidson A. What is damaging the kidney in lupus nephritis? Nat Rev Rheumatol 2016; 12: 143-53.
  10. Apostolidis SA, Lieberman LA, Kis-Toth K, et al. The dysregulation of cytokine networks in systemic lupus erythematosus. J Interferon Cytokine Res 2011; 31: 769-79.
  11. Crispín JC, Oukka M, Bayliss G, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008; 181: 8761-6.
  12. Chen DY, Chen YM, Wen MC, et al. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus 2012; 21: 1385-96.
  13. Koga T, Ichinose K, Tsokos GC. T cells and IL-17 in lupus nephritis. Clin Immunol 2017; 185: 95-9.
  14. Michaelson JS, Wisniacki N, Burkly LC, Putterman C. Role of TWEAK in lupus nephritis: a bench-to-bedside review. J Autoimmun 2012; 39: 130-42.
  15. Burkly LC, Michaelson JS, Hahm K, et al. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokine 2007; 40: 1-16.
  16. Zhao Z, Burkly LC, Campbell S, et al. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol 2007; 179: 7949-58.
  17. Wen J, Doerner J, Chalmers S, et al. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine lupus. J Immunol 2015; 194: 1701-8.
  18. Schwartz N, Su L, Burkly LC, et al. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther 2009; 11: R143.
  19. El-Shehaby A, Darweesh H, El-Khatib M, et al. Correlation of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis. J Clin Immunol 2011; 31: 848-56.
  20. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 2019; 71: 1400-12.
  21. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677-86.
  22. Sun CY, Shen Y, Chen XW, et al. The characteristics and significance of locally infiltrating B cells in lupus nephritis and their association with local BAFF expression. Int J Rheum Dis 2013; 16: 683-90.
  23. Pan H, Zhang W, Liu Y, et al. Interleukin-17A exacerbates lupus nephritis through promoting neutrophil infiltration. Immunol Lett 2020; 217: 1-9.
  24. Kwan BC, Tam LS, Lai KB, et al. The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. Rheumatology 2009; 48: 1491-7.
  25. Xia Y, Campbell SR, Broder A, et al. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis. Clin Immunol 2012; 145: 108-21.
  26. Fairhurst AM, Xie C, Fu Y, et al. Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. J Immunol 2009; 183: 6831-8.
  27. Li P, Liu Y, Qin X, et al. TWEAK/Fn14 interaction confers aggressive properties to cutaneous squamous cell carcinoma. J Invest Dermatol 2019; 139: 796-806.
  28. Liu CC, Kao AH, Manzi S, Ahearn JM. Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Ther Adv Musculoskelet Dis 2013; 5: 210-33.
  29. Carlomagno AL, Alves GS, de Azevedo MSP, et al. A panel of biomarkers associates with increased risk for renal flare in systemic lupus erythematosus patients with quiescent disease. J Rheumatol 2021; 48: 1708-17.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications